3-15635591-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 3P and 6B. PM1PP2BP4_StrongBP6BS2_Supporting
The NM_001370658.1(BTD):c.152T>C(p.Leu51Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000688 in 1,614,216 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001370658.1 missense
Scores
Clinical Significance
Conservation
Publications
- biotinidase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370658.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTD | NM_001370658.1 | MANE Select | c.152T>C | p.Leu51Pro | missense | Exon 2 of 4 | NP_001357587.1 | ||
| BTD | NM_001281723.4 | c.152T>C | p.Leu51Pro | missense | Exon 2 of 4 | NP_001268652.2 | |||
| BTD | NM_001281724.3 | c.152T>C | p.Leu51Pro | missense | Exon 4 of 6 | NP_001268653.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTD | ENST00000643237.3 | MANE Select | c.152T>C | p.Leu51Pro | missense | Exon 2 of 4 | ENSP00000495254.2 | ||
| BTD | ENST00000303498.10 | TSL:1 | c.152T>C | p.Leu51Pro | missense | Exon 3 of 5 | ENSP00000306477.6 | ||
| BTD | ENST00000427382.2 | TSL:4 | c.152T>C | p.Leu51Pro | missense | Exon 2 of 4 | ENSP00000397113.2 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00154 AC: 386AN: 251432 AF XY: 0.00216 show subpopulations
GnomAD4 exome AF: 0.000731 AC: 1068AN: 1461894Hom.: 25 Cov.: 32 AF XY: 0.00112 AC XY: 811AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000276 AC: 42AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Biotinidase deficiency Benign:4
The heterozygous p.Leu71Pro variant in BTD has been identified in the compound heterozygous state, in trans with a frameshift variant and in cis with a rare missense variant, in an individual from Hungary with biotinidase deficiency (PMID: 14707518). This variant has also been identified in >1% of South Asian chromosomes and 8 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal recessive biotinidase deficiency.
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
not specified Uncertain:1Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at